AIM ImmunoTech Inc. entered into a securities purchase agreement with institutional investors for a registered direct offering and a concurrent private placement. The company expects to raise approximately $1.3 million in initial gross proceeds, with the potential for an additional $5.3 million if all warrants issued in the transaction are exercised for cash.
Key Details
- Registered Offering: Sale of 2,554,119 shares of common stock at a price of $0.5189 per share, generating gross proceeds of approximately $1.3 million.
- Private Placement: In a concurrent private placement, investors will receive 771,503 shares, pre-funded warrants to purchase 1,782,616 shares, and Class J warrants to purchase 10,216,476 shares.
- Warrant Terms: Pre-funded warrants have an exercise price of $0.001 per share and are immediately exercisable. Class J warrants have an exercise price of $0.5189 per share and expire five years after stockholder approval.
- Closing Date: The offerings are expected to close on or about June 10, 2026, subject to customary closing conditions.